Bitcoin ( BTC-USD ) briefly fell below the average price paid by its largest corporate buyer, Strategy ( MSTR ), narrowing the margin for error in Michael Saylor's massive, leveraged bet on the highest-profile crypto. The price of bitcoin ( BTC-USD ) tumbled early Monday to as low as $74.6K—testing 52-week lows—as the wider crypto-market selloff deepened. That fell short of Strategy's ( MSTR ) ave...
Bitcoin ( BTC-USD ) briefly fell below the average price paid by its largest corporate buyer, Strategy ( MSTR ), narrowing the margin for error in Michael Saylor's massive, leveraged bet on the highest-profile crypto. The price of bitcoin ( BTC-USD ) tumbled early Monday to as low as $74.6K—testing 52-week lows—as the wider crypto-market selloff deepened. That fell short of Strategy's ( MSTR ) average price paid on its 713,502 BTC of about $76.1K apiece. In late morning trading, though, BTC was changing hands at $78.7K in a modest recovery over the last 24 hours, but it's down roughly 40% from its record high in October. Strategy ( MSTR ), formerly MicroStrategy, is known for using its balance sheet and repeated equity and debt issuances to buy and hold large amounts of bitcoin ( BTC-USD ), treating it as a long-term treasury reserve. MSTR is viewed as a high-beta proxy for BTC. The company's BTC total holdings stood at $54.3B as of Feb. 1. While the company is not under immediate financial strain, its flexibility is diminishing unless bitcoin ( BTC-USD ) meaningfully recovers or investors remain willing to buy its shares, which were off nearly 60% Y/Y. Beyond mark-to-market losses, Strategy's ( MSTR ) treasury model depends on its shares trading at a premium to its BTC holdings — a premium that has narrowed markedly since late last year, Seeking Alpha analyst Pacifica Yield had pointed out. "This new zeitgeist represents MSTR's most intense stress test ," the SA contributor wrote. "It could really come to represent a permanent step change in the company's prospects, a rollback of the highly lucrative BTC accumulation strategy that allowed the constant issuance of new common equity to buy BTC." More on Strategy, Bitcoin USD Bitcoin's Fall: Why Now Is The Time For A Contrarian-Long IBIT Play Strategy: Bitcoin As A Treasury Model Faces Stress Test Whale's Market Outlook 2026: Crypto Majors, Perp DEXs, And Prediction Markets Investors should expect 8-9 more weeks of co...
UK Prime Minister Keir Starmer called on Monday for Britain’s former ambassador to the US, Peter Mandelson, to be removed from parliament’s upper chamber after new reports emerged of his ties with the late US sex offender Jeffrey Epstein. Mandelson, a prominent figure in Starmer’s Labour Party for decades, was fired from his envoy role last year after previous revelations about his connections to...
UK Prime Minister Keir Starmer called on Monday for Britain’s former ambassador to the US, Peter Mandelson, to be removed from parliament’s upper chamber after new reports emerged of his ties with the late US sex offender Jeffrey Epstein. Mandelson, a prominent figure in Starmer’s Labour Party for decades, was fired from his envoy role last year after previous revelations about his connections to Epstein. Late on Sunday, the former minister under Labour’s 1997-2007 prime minister Tony Blair quit the centre-left party after more documents were released, saying he did not wish to cause “further embarrassment”. Advertisement The newly released documents from the US Justice Department showed Mandelson pictured in his underwear, an image that circulated widely in British media on Monday. The Financial Times said the files also showed that accounts connected to Mandelson had received US$75,000 from Epstein, prompting opposition politicians to call for a full investigation. Peter Mandelson apologised in a letter to the Labour Party for being linked again to Jeffrey Epstein. Photo: AP ‘Understandable furore’, Mandeslon says
We have selected seven of the most interesting and important news stories covering Latin America relations from the past few weeks. If you would like to see more of our reporting, please consider subscribing 1. US won’t rule out pressuring Venezuela to curb China, Russia ties Photo: pool via EPA In the wake of the abduction of Venezuelan leader Nicolas Maduro on January 3, the White House stopped ...
We have selected seven of the most interesting and important news stories covering Latin America relations from the past few weeks. If you would like to see more of our reporting, please consider subscribing 1. US won’t rule out pressuring Venezuela to curb China, Russia ties Photo: pool via EPA In the wake of the abduction of Venezuelan leader Nicolas Maduro on January 3, the White House stopped short of denying reports that America had urged Venezuela to cut ties with US adversaries such as China, Russia and Iran. Read the full story here 2. US ousting of Maduro prompts region to reassess China – and Trump’s next move Photo: Xinhua The US military operation that captured Venezuela’s president in early January is likely to force governments across Latin America to reassess how far China and Russia can protect their partners when Washington decides to act, analysts said, as the United States signalled a more assertive approach to the region. Advertisement Read the full story here 3. How China’s 15-fold rise in Latin America dents US influence: Francisco Urdinez Illustration: Lau Ka-kuen One of the leading scholars of China-Latin America relations, Francisco Urdinez is known for coining the concept of “economic displacement”, describing how China’s rise has reduced US relevance in the region. Now, in the wake of the abduction of Nicolas Maduro, Urdinez examines how Venezuela could upend that framework and reshape perceptions of US-China competition in Latin America and beyond.
In trading on Monday, shares of the SPDR Portfolio Short Term Treasury ETF (Symbol: SPTS) crossed below their 200 day moving average of $29.14, changing hands as low as $29.10 per share. SPDR Portfolio Short Term Treasury shares are currently trading off about 0.2% on the day. The chart below shows the one year performance of SPTS shares, versus its 200 day moving average: Looking at the chart abo...
In trading on Monday, shares of the SPDR Portfolio Short Term Treasury ETF (Symbol: SPTS) crossed below their 200 day moving average of $29.14, changing hands as low as $29.10 per share. SPDR Portfolio Short Term Treasury shares are currently trading off about 0.2% on the day. The chart below shows the one year performance of SPTS shares, versus its 200 day moving average: Looking at the chart above, SPTS's low point in its 52 week range is $28.71 per share, with $29.46 as the 52 week high point — that compares with a last trade of $29.11. Click here to find out which 9 other ETFs recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Tuesday, shares of the SPDR Bloomberg Investment Grade Floating Rate ETF (Symbol: FLRN) crossed below their 200 day moving average of $30.74, changing hands as low as $30.69 per share. SPDR Bloomberg Investment Grade Floating Rate shares are currently trading down about 0.5% on the day. The chart below shows the one year performance of FLRN shares, versus its 200 day moving average: ...
In trading on Tuesday, shares of the SPDR Bloomberg Investment Grade Floating Rate ETF (Symbol: FLRN) crossed below their 200 day moving average of $30.74, changing hands as low as $30.69 per share. SPDR Bloomberg Investment Grade Floating Rate shares are currently trading down about 0.5% on the day. The chart below shows the one year performance of FLRN shares, versus its 200 day moving average: Looking at the chart above, FLRN's low point in its 52 week range is $30.32 per share, with $30.88 as the 52 week high point — that compares with a last trade of $30.70. Click here to find out which 9 other ETFs recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
J Studios/DigitalVision via Getty Images Steve Levy, editor at large at Wired, warned that the massive capital investments pouring into artificial intelligence are unlikely to generate returns that match their scale anytime soon. In an interview with CNBC, Levy characterized the spending spree by major technology companies as one of the most significant economic questions of our time, noting that ...
J Studios/DigitalVision via Getty Images Steve Levy, editor at large at Wired, warned that the massive capital investments pouring into artificial intelligence are unlikely to generate returns that match their scale anytime soon. In an interview with CNBC, Levy characterized the spending spree by major technology companies as one of the most significant economic questions of our time, noting that the high valuations of these hyperscalers affect the broader market. The scope of corporate spending on AI infrastructure has reached staggering levels, with companies going “all in” on building massive data centers. OpenAI ( OPENAI ) is reportedly seeking to raise up to $50B this year to expand its cloud infrastructure operations, while Meta ( META ) and Microsoft ( MSFT ) have both promised increased AI capital expenditures in their latest reports. Oracle ( ORCL ) has similarly committed heavily to the buildout, reflecting an industry-wide belief that bigger investments will yield bigger breakthroughs. Yet the market’s reaction to these expenditures has been inconsistent, swinging between optimism about companies being “serious” about AI and concern over when investors will see a payoff. Levy observed that these tech giants have “pushed all their chips to the center of the table” on this bet, but whether it pays off depends on AI becoming deeply integrated into everyday life. The outcome remains uncertain, as success hinges on the premise that scaling up models and data centers will inevitably deliver results. The industry’s strategy rests on what Levy described as a kind of technological “Valhalla”—a vision of abundance where AI solves major problems, as promoted by leaders like OpenAI’s ( OPENAI ) Sam Altman. However, reaching this promised land requires AI to progress in ways that demand hundreds of billions of dollars in infrastructure investment. The risk is that the bet on technical scaling may not automatically translate into economic productivity. Levy noted that ...
In trading on Wednesday, shares of the BlackRock Ultra Short-Term Bond ETF (Symbol: ICSH) crossed below their 200 day moving average of $50.05, changing hands as low as $50.04 per share. BlackRock Ultra Short-Term Bond shares are currently trading off about 0.3% on the day. The chart below shows the one year performance of ICSH shares, versus its 200 day moving average: Looking at the chart above,...
In trading on Wednesday, shares of the BlackRock Ultra Short-Term Bond ETF (Symbol: ICSH) crossed below their 200 day moving average of $50.05, changing hands as low as $50.04 per share. BlackRock Ultra Short-Term Bond shares are currently trading off about 0.3% on the day. The chart below shows the one year performance of ICSH shares, versus its 200 day moving average: Looking at the chart above, ICSH's low point in its 52 week range is $49.84 per share, with $50.30 as the 52 week high point — that compares with a last trade of $50.04. Click here to find out which 9 other ETFs recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Monday, shares of the PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund ETF (Symbol: HYS) crossed below their 200 day moving average of $94.61, changing hands as low as $94.52 per share. PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund shares are currently trading off about 0.6% on the day. The chart below shows the one year performance of HYS sha...
In trading on Monday, shares of the PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund ETF (Symbol: HYS) crossed below their 200 day moving average of $94.61, changing hands as low as $94.52 per share. PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund shares are currently trading off about 0.6% on the day. The chart below shows the one year performance of HYS shares, versus its 200 day moving average: Looking at the chart above, HYS's low point in its 52 week range is $88.7932 per share, with $95.88 as the 52 week high point — that compares with a last trade of $94.65. Click here to find out which 9 other ETFs recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Monday, shares of Pitney Bowes Inc (Symbol: PBI) crossed above their 200 day moving average of $10.58, changing hands as high as $10.59 per share. Pitney Bowes Inc shares are currently trading up about 1.3% on the day. The chart below shows the one year performance of PBI shares, versus its 200 day moving average: Looking at the chart above, PBI's low point in its 52 week range is $7...
In trading on Monday, shares of Pitney Bowes Inc (Symbol: PBI) crossed above their 200 day moving average of $10.58, changing hands as high as $10.59 per share. Pitney Bowes Inc shares are currently trading up about 1.3% on the day. The chart below shows the one year performance of PBI shares, versus its 200 day moving average: Looking at the chart above, PBI's low point in its 52 week range is $7.395 per share, with $13.11 as the 52 week high point — that compares with a last trade of $10.56. Click here to find out which 9 other stocks recently crossed above their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In trading on Monday, shares of the State Street SPDR Bloomberg Short Term High Yield Bond ETF (Symbol: SJNK) crossed below their 200 day moving average of $25.32, changing hands as low as $25.27 per share. State Street SPDR Bloomberg Short Term High Yield Bond shares are currently trading off about 0.5% on the day. The chart below shows the one year performance of SJNK shares, versus its 200 day ...
In trading on Monday, shares of the State Street SPDR Bloomberg Short Term High Yield Bond ETF (Symbol: SJNK) crossed below their 200 day moving average of $25.32, changing hands as low as $25.27 per share. State Street SPDR Bloomberg Short Term High Yield Bond shares are currently trading off about 0.5% on the day. The chart below shows the one year performance of SJNK shares, versus its 200 day moving average: Looking at the chart above, SJNK's low point in its 52 week range is $23.92 per share, with $25.65 as the 52 week high point — that compares with a last trade of $25.30. Click here to find out which 9 other ETFs recently crossed below their 200 day moving average » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image source: The Motley Fool. Monday, Feb. 2, 2026 at 10 a.m. ET Call participants Senior Vice President and Chief Financial Officer — Cary Marshall Chairman, President, and Chief Executive Officer — Joseph Craft Need a quote from a Motley Fool analyst? Email [email protected] Takeaways Adjusted EBITDA -- $191.1 million, up 54.1% year over year and 2.8% sequentially, driven by lower expenses, low...
Image source: The Motley Fool. Monday, Feb. 2, 2026 at 10 a.m. ET Call participants Senior Vice President and Chief Financial Officer — Cary Marshall Chairman, President, and Chief Executive Officer — Joseph Craft Need a quote from a Motley Fool analyst? Email [email protected] Takeaways Adjusted EBITDA -- $191.1 million, up 54.1% year over year and 2.8% sequentially, driven by lower expenses, lower impairments, and investment income. -- $191.1 million, up 54.1% year over year and 2.8% sequentially, driven by lower expenses, lower impairments, and investment income. Net income attributable to ARLP -- $82.7 million, or $0.64 per unit, compared to $16.3 million, or $0.12 per unit, year over year, reflecting improved operating leverage and investment gains. -- $82.7 million, or $0.64 per unit, compared to $16.3 million, or $0.12 per unit, year over year, reflecting improved operating leverage and investment gains. Total revenues -- $535.5 million, down from $590.1 million year over year, primarily due to weaker coal sales and transportation revenues, partially offset by record oil and gas royalty volume. -- $535.5 million, down from $590.1 million year over year, primarily due to weaker coal sales and transportation revenues, partially offset by record oil and gas royalty volume. Coal sales price per ton -- $57.57, representing a decrease of 4% year over year and 2.1% sequentially as higher-priced legacy contracts roll off. -- $57.57, representing a decrease of 4% year over year and 2.1% sequentially as higher-priced legacy contracts roll off. Total coal production -- 8.2 million tons, up from 6.9 million tons year over year; wholesale volumes were 8.1 million tons, down from 8.4 million year over year and 8.7 million sequentially. -- 8.2 million tons, up from 6.9 million tons year over year; wholesale volumes were 8.1 million tons, down from 8.4 million year over year and 8.7 million sequentially. Coal segment adjusted EBITDA expense per ton sold -- $40.24, decreasing...
narkorn/iStock via Getty Images The United Steelworkers union has neither accepted nor rejected the last offer from Marathon Petroleum ( MPC ) for a new four-year labor agreement for U.S. refineries and chemical plants, Reuters reported Monday. The offer, made in negotiations over the weekend, would give 30K workers represented by the USW union a 15% pay increase over the length of the contract, t...
narkorn/iStock via Getty Images The United Steelworkers union has neither accepted nor rejected the last offer from Marathon Petroleum ( MPC ) for a new four-year labor agreement for U.S. refineries and chemical plants, Reuters reported Monday. The offer, made in negotiations over the weekend, would give 30K workers represented by the USW union a 15% pay increase over the length of the contract, the report said. A strike by the 30K workers at U.S. refineries and chemical plants was averted for now after the USW said late Saturday it would extend talks with Marathon ( MPC ). Marathon ( MPC ), the largest U.S. refiner, is the lead negotiator for 26 companies including Exxon Mobil ( XOM ), Chevron ( CVX ) and Valero Energy ( VLO ); USW-represented workers operate sites that account for nearly two-thirds of U.S. refining capacity of 18.3M bbl/day. Workers and the company settled local issues on Friday at Marathon's ( MPC ) largest refinery, the 631K bbl/day Galveston Bay refinery in Texas. More on Marathon Petroleum Cheaper Heavy Crude Might Come For Marathon Petroleum Corporation Marathon Petroleum: Buybacks Outweigh Q3 Noise Marathon Petroleum Q3 2025 Earnings Call Presentation
Veronique D Amgen’s ( AMGN ) fourth-quarter earnings on Tuesday will have investors looking out for developments around the company’s obesity drug candidate MariTide. Analysts expect the company to post earnings of $4.76 , representing a 10.4% drop from the corresponding period of the previous year. Revenue is expected to rise 4% to $9.46B. Over the last 3 months, EPS estimates have seen 1 upward ...
Veronique D Amgen’s ( AMGN ) fourth-quarter earnings on Tuesday will have investors looking out for developments around the company’s obesity drug candidate MariTide. Analysts expect the company to post earnings of $4.76 , representing a 10.4% drop from the corresponding period of the previous year. Revenue is expected to rise 4% to $9.46B. Over the last 3 months, EPS estimates have seen 1 upward revision and 18 downward moves, while revenue estimates have seen 14 upward revisions and 3 downward moves. Earlier this month, UBS upgraded Amgen to Buy from Neutral, saying that two of its late-stage assets, MariTide for obesity and olpasiran for cardiovascular risk reduction, should drive growth through 2030. Analyst Michael Yee believes MariTide could have an edge due to its potential once-monthly GLP-1 dosing. Although trial results raised tolerability concerns, he said Amgen is likely to use a new three-step titration approach that could significantly improve tolerability and reduce discontinuations. This could potentially support Phase III weight loss of 15–20% while maintaining monthly dosing and an adverse event profile similar to Eli Lilly’s ( LLY ) tirzepatide. Bernstein also noted that MariTide, with only a mid-single-digit percentage of the market, will exceed consensus expectations. “This product doesn’t need to be perfect, but rather just provide a differentiated product in the market, with the dose interval being the critical differentiating factor & adverse event profile acceptable,” analyst Courtney Breen said. However, she added that any upside revisions to this product are unlikely to be reflected until the first phase 3 trial in the first quarter of 2027. Breen also highlighted further challenges for the company this year, including rising competition for its cholesterol drug Repatha from Merck’s ( MRK ) oral PCSK9 inhibitor, Enlicitide, which is expected to launch in the second half of the year. Moreover, Seeking Alpha analyst Edmund Ingham also appear...